Alnylam Pharmaceuticals ALNY Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alnylam Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alnylam Pharmaceuticals's free cash flow?
- Alnylam Pharmaceuticals (ALNY) reported free cash flow of $48.67M in Q1 2026.
- How has Alnylam Pharmaceuticals's free cash flow changed year-over-year?
- Alnylam Pharmaceuticals's free cash flow increased by 137.6% year-over-year, from -$129.28M to $48.67M.
- What is the long-term trend for Alnylam Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2025), Alnylam Pharmaceuticals's free cash flow has grown at a -13.5% compound annual growth rate (CAGR), from -$718.07M to $465.38M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.